Curcumin in the treatment of liver cancer: From mechanisms of action to nanoformulations
Phytotherapy Research · 2023-04 · 37 (4) · 1624-1639
DOI: 10.1002/ptr.7757 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, published online on 2023-03-08. Written by Sulieman Ibraheem Shelash Al-Hawary and 11 co-authors. Institution: Department of Business Administration, Business School, Al al-Bayt University, Mafraq, Jordan. Major MEDLINE topics: Curcumin, Liver Neoplasms. Cited 59 times so far (Crossref); 155 references. Funded by: Scientific Research Deanship at King Khalid University, Abha, Saudi Arabia through the Large Research Group Project.
Abstract (original language)
Liver cancer is the sixth most prevalent cancer and ranks third in cancer‐related death, after lung and colorectal cancer. Various natural products have been discovered as alternatives to conventional cancer therapy strategies, including radiotherapy, chemotherapy, and surgery. Curcumin (CUR) with antiinflammatory, antioxidant, and antitumor activities has been associated with therapeutic benefits against various cancers. It can regulate multiple signaling pathways, such as PI3K/Akt, Wnt/β‐catenin, JAK/STAT, p53, MAPKs, and NF‐ĸB, which are involved in cancer cell proliferation, metastasis, apoptosis, angiogenesis, and autophagy. Due to its rapid metabolism, poor oral bioavailability, and low solubility in water, CUR application in clinical practices is restricted. To overcome these limitations, nanotechnology‐based delivery systems have been applied to use CUR nanoformulations with added benefits, such as reducing toxicity, improving cellular uptake, and targeting tumor sites. Besides the anticancer activities of CUR in combating various cancers, especially liver cancer, here we focused on the CUR nanoformulations, such as micelles, liposomes, polymeric, metal, and solid lipid nanoparticles, and others, in the treatment of liver cancer.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Business Administration, Business School, Al al-Bayt University, Mafraq, Jordan.
- Medical Laboratory Techniques Department, Al-maarif University College, Al-Anbar-Ramadi, Iraq.
- Medical Laboratory Techniques Department, Al-Farahidi University, Baghdad, Iraq.
- Medical Laboratory Techniques Department, Al-Turath University College, Baghdad, Iraq.
- College of Pharmacy, Al-Ayen University, Nasiriyah, Iraq.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
ORCID profiles: Irfan Ahmad, Yasser Fakri Mustafa
Funding
- Scientific Research Deanship at King Khalid University, Abha, Saudi Arabia through the Large Research Group Project
Cite
APA
Shelash Al-Hawary, S. I., Abdalkareem Jasim, S., M Kadhim, M., Jaafar Saadoon, S., Ahmad, I., Romero Parra, R. M., Hasan Hammoodi, S., Abulkassim, R., M Hameed, N., K Alkhafaje, W., Mustafa, Y. F., & Javed Ansari, M. (2023). Curcumin in the treatment of liver cancer: From mechanisms of action to nanoformulations. Phytotherapy Research, 37(4), 1624-1639. https://doi.org/10.1002/ptr.7757
Vancouver
Shelash Al-Hawary SI, Abdalkareem Jasim S, M Kadhim M, Jaafar Saadoon S, Ahmad I, Romero Parra RM, et al. Curcumin in the treatment of liver cancer: From mechanisms of action to nanoformulations. Phytotherapy Research. 2023;37(4):1624-1639. doi:10.1002/ptr.7757
BibTeX
@article{ShelashAlHawary2023,
author = {Shelash Al-Hawary, Sulieman Ibraheem and Abdalkareem Jasim, Saade and M Kadhim, Mustafa and Jaafar Saadoon, Sarah and Ahmad, Irfan and Romero Parra, Rosario Mireya and Hasan Hammoodi, Suzan and Abulkassim, Roua and M Hameed, Noora and K Alkhafaje, Waleed and Mustafa, Yasser Fakri and Javed Ansari, Mohammad},
title = {Curcumin in the treatment of liver cancer: From mechanisms of action to nanoformulations},
journal = {Phytotherapy Research},
year = {2023},
volume = {37},
number = {4},
pages = {1624--1639},
doi = {10.1002/ptr.7757}
}
EUVIMED